Peak Frameworks

AUGUST 15, 2023

Insider trading , a highly controversial topic in financial ethics and law, involves the trading of a public company's stock by individuals with access to non-public, material information about the company. Contrary to popular belief, not all insider trading is illegal.

Trading 52

Trading Financial Market Stock Investors 52

The TRADE

FEBRUARY 20, 2024

At the TradeTech FX US conference in Miami last week, a panel of experts including some of the largest asset managers gathered to discuss what the market is prioritising when asking the ever-hot topic of ‘buy versus build,’ sharing their perspectives and empirical advice for 2024 and beyond.

Asset Management 57

Asset Management Management Architecture Trading 57

The TRADE

JANUARY 11, 2024

The notion of the ‘ideal trader’ was a key topic across numerous conferences and industry reunions last year, where experts across the buy- and sell-side seemingly agree that the optimum mix is a high performing quant individual with a good grasp of data combined with a sociable attitude.

Trading 78

Trading Management Education Investment Manager 78

The TRADE

DECEMBER 21, 2023

This realisation became one of the catalysts which has sparked more of an acceptance of outsourcing parts of the trading desk among buy-side firms, something which many once considered – though some still do – an unthinkable concept. Outsourced trading is no longer a taboo topic. It’s no longer all or nothing.

Trading 62

Trading Management Asset Management Funds 62

The TRADE

AUGUST 21, 2023

Among the SEC’s reforms is the proposal to amend certain rules under Reg NMS to adopt variable minimum pricing increments – or tick sizes – for the quoting and trading of NMS stocks. Looking at tick size too, if you don’t get that right, you can reduce and fragment liquidity and make it more costly to trade.”

Equities 52

Equities Retail Trading Broker 52

FineMark

OCTOBER 17, 2023

We revisited this topic during our recent Investment Policy Committee meeting, and believe this theme will persist in driving corporate and policymakers’ decisions. As shown below in Figure 3, over the past five years both Mexico and Canada have disproportionately benefitted from our reduced trade with China.

S&P 52

S&P Investment Portfolio Corporation 52

Cooley M&A

JANUARY 23, 2024

The headwinds Antitrust scrutiny continues Perhaps the biggest headwind of all is continuing scrutiny from antitrust agencies inside and outside the US. Moving into Q2 of 2023, roughly 29% of US public biotech companies traded below their cash value. billion.

M&A 52

M&A Mergers and Acquisitions Pharmaceutical Acquisitions 52